U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
100291100291Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial FlutterCompletedNo Results AvailableAtrial FlutterDevice: Blazer® Open-Irrigated Ablation Catheter|Device: Control Catheterhttps://ClinicalTrials.gov/show/NCT01253200
100292100292Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: YAZ and YAZ + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and YAZCompletedHas ResultsContraceptionDrug: EE 0.02 mg/DRSP 3 mg (YAZ, BAY86-5300)|Drug: EE 0.02 mg/DRSP 3 mg/L-5-MTHF Ca 0.451 mg (EE20/DRSP/L-5-MTHF Ca)|Drug: L-5-MTHF 0.451mg (Metafolin)https://ClinicalTrials.gov/show/NCT01253187
100293100293Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: Yasmin and Yasmin + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) aCompletedHas ResultsContraceptionDrug: EE 0.03 mg/DRSP 3 mg (Yasmin, BAY86-5131)|Drug: EE 0.03mg/DRSP 3mg/L-5-MTHF Ca 0.451mg (EE30/DRSP/L-5-MTHF Ca)|Drug: L-5-MTHF Ca 0.451 mg (Metafolin)https://ClinicalTrials.gov/show/NCT01253174
100294100294Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)Active, not recruitingNo Results AvailableNeuroendocrine Tumors|Carcinoid TumorsDrug: Pasireotide Long Acting Release (LAR)https://ClinicalTrials.gov/show/NCT01253161
100295100295Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for CholangiocarcinomaCompletedNo Results AvailableCholangiocarcinomaDevice: TheraSphere® Yttrium-90 (Y-90) Microsphereshttps://ClinicalTrials.gov/show/NCT01253148
100296100296Study to Determine if Fibrin Affects the Ability of a Wound to HealCompletedNo Results AvailableEffect of Test Articles on the Healing of a Wound Artificially Induced by Liquid Nitrogen SprayOther: Fibrin|Other: White Petrolatumhttps://ClinicalTrials.gov/show/NCT01253135
100297100297Comparative Bioavailability in Healthy Elderly VolunteersCompletedNo Results AvailableAlzheimer's DiseaseDrug: TRx0037https://ClinicalTrials.gov/show/NCT01253122
100298100298Continuous Intraocular Pressure (IOP) Monitoring in Pigmentary Dispersion Syndrome and Pigmentary Glaucoma PatientsTerminatedNo Results AvailablePigmentary Dispersion Syndrome|Pigmentary Glaucoma PatientsDevice: SENSIMED Triggerfishhttps://ClinicalTrials.gov/show/NCT01253109
100299100299Intratumoral Application of L19IL2 in Patients With Malignant MelanomaCompletedNo Results AvailableMalignant MelanomaDrug: Intratumoral injections of L19IL2https://ClinicalTrials.gov/show/NCT01253096
100300100300Mobility Training to Improve Motor Behavior in Toddlers With or at Risk for Cerebral Palsy: A Pilot StudyCompletedNo Results AvailableDevelopmental Delay|Cerebral PalsyBehavioral: mobility training with dynamic body weight supporthttps://ClinicalTrials.gov/show/NCT01253083
100301100301Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid LeukemiaActive, not recruitingNo Results AvailableAcute Myeloid Leukemia (Megakaryoblastic) With t(1;22)(p13;q13); RBM15-MKL1|Acute Myeloid Leukemia With a Variant RARA Translocation|Acute Myeloid Leukemia With Inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1|Acute Myeloid Leukemia With t(6;9)(p23;q34); Drug: Daunorubicin Hydrochloride|Drug: Sorafenib Tosylate|Drug: Cytarabine|Procedure: Bone Marrow Aspiration|Procedure: Biopsy|Other: Laboratory Biomarker Analysis|Other: Quality-of-Life Assessment|Other: Questionnaire Administrationhttps://ClinicalTrials.gov/show/NCT01253070
100302100302A Research on the Hospital Pollution Control and Hygine Intervention of Chemotherapy Drugs ExposureActive, not recruitingNo Results AvailableSister-chromatic-exchange(SCE)|Micronuclei(MN)https://ClinicalTrials.gov/show/NCT01253057
100303100303Acceptance and Commitment Therapy (ACT) for OEF/OIF VeteransActive, not recruitingNo Results AvailableDistress|Anxiety|Depression|Postconcussive SymptomsBehavioral: Acceptance and Commitment Therapy|Behavioral: Present Centered Therapyhttps://ClinicalTrials.gov/show/NCT01253044
100304100304Auditory Working Memory StudyCompletedNo Results AvailableAging|Hearing Losshttps://ClinicalTrials.gov/show/NCT01253031
100305100305Evaluation of Robot Assisted Neuro-RehabilitationActive, not recruitingNo Results AvailableStrokeBehavioral: Upper extremity exercise|Behavioral: Upper extremity robotic exercisehttps://ClinicalTrials.gov/show/NCT01253018
100306100306The Effect of Physical Properties of Lipid Emulsions on Gastrointestinal FunctionCompletedNo Results AvailableHealthy ControlsBehavioral: Nutritional interventionhttps://ClinicalTrials.gov/show/NCT01253005
100307100307Paradoxical Reactions in Non Immuno-compromized Patients With Extrapulmonary TuberculosisRecruitingNo Results AvailableExtrapulmonary TuberculosisGenetic: Genetic analysis|Radiation: Body scan (CERVICO THORACO ABDOMINAL) + Cranian IRM|Other: Immunologic analysis|Other: QuantiferonTB Gold testhttps://ClinicalTrials.gov/show/NCT01252992
100308100308Ketones & Mitochondrial HeteroplasmyCompletedNo Results AvailableMELAS Syndrome|Mitochondrial DiseasesDietary Supplement: Medium-Chain Triglycerideshttps://ClinicalTrials.gov/show/NCT01252979
100309100309Cognitive Training for Nicotine DependenceActive, not recruitingNo Results AvailableTobacco Use Disorder|Nicotine AddictionBehavioral: Cognitive Remediation Training (CRT)|Behavioral: Standard Care (SC)https://ClinicalTrials.gov/show/NCT01252966
100310100310REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modificationActive, not recruitingNo Results AvailableAtherosclerotic Cardiovascular DiseaseDrug: anacetrapib|Drug: placebo anacetrapibhttps://ClinicalTrials.gov/show/NCT01252953
100311100311Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DFCompletedHas ResultsHIV-1 InfectionDrug: FTC/RPV/TDF|Drug: PI|Drug: RTV|Drug: NRTIshttps://ClinicalTrials.gov/show/NCT01252940
100312100312Evaluation of a Gatekeeper Training ProgramActive, not recruitingNo Results AvailableSuicideOther: ASISThttps://ClinicalTrials.gov/show/NCT01252927
100313100313A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal StentActive, not recruitingNo Results AvailableSubject With Primary Open-angle Glaucoma (POAG)Device: iStent Supra Stenthttps://ClinicalTrials.gov/show/NCT01252914
100314100314Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated DiseasesCompletedNo Results AvailableDenys-Drash Syndrome|Frasier Syndrome|Nephrotic Syndrome|Wilms Tumorhttps://ClinicalTrials.gov/show/NCT01252901
100315100315Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStentsActive, not recruitingNo Results AvailableSubjects With Primary Open-angle Glaucoma (POAG)Device: iStentshttps://ClinicalTrials.gov/show/NCT01252888
100316100316Treat Stroke to TargetRecruitingNo Results AvailableIschemic Stroke|Transient Ischemic Attack|Atherosclerotic StenosisProcedure: Target : 100 mg/dL (+/-10 mg/dL)|Procedure: 70 mg/dLhttps://ClinicalTrials.gov/show/NCT01252875
100317100317Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStentsActive, not recruitingNo Results AvailableSubjects With Primary Open-angle Glaucoma (POAG)Device: iStenthttps://ClinicalTrials.gov/show/NCT01252862
100318100318Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma SubjectsActive, not recruitingNo Results AvailablePrimary Open Angle Glaucoma (POAG)Device: iStent|Device: iStent|Device: iStenthttps://ClinicalTrials.gov/show/NCT01252849
100319100319Study Evaluating AWBAT-D Versus the Standard of Care of Split-thickness Skin Graft Donor SitesTerminatedNo Results AvailableHealing of Donor Site|Pain LevelDevice: AWBAT-Dhttps://ClinicalTrials.gov/show/NCT01252836
100320100320Implantable Loop Recorder in Hemodialysis PatientsActive, not recruitingNo Results AvailableHemodialysis|Cardiac Arrhythmia|Cardiac DeathDevice: Implantation of ILRhttps://ClinicalTrials.gov/show/NCT01252823

* Görseller ve İçerik tekif hakkına sahip olabilir